GLP-1 side effects on TikTok: what's real vs. overdramatised

What did @freyas.journey20 actually say?

Not much, honestly. The transcript here is thin: "You're not sick. No, no, in fact. Helen, I'm hungry and I wish I had a snack." That's the whole thing. The caption promises transparency about GLP-1 side effects, which the creator describes as "not fun," but the spoken content captured here doesn't actually explain what those side effects are. What comes through clearly is that hunger is still present, which runs counter to a common public assumption about GLP-1 medications.

To be fair to the creator, TikTok videos often carry meaning through visuals, tone, and context that a transcript alone can't capture. The caption framing suggests this is a personal experience video, not a medical advice video, which is appropriate territory for a patient sharing their journey.

Does the science back this up?

The implicit claim here, that GLP-1 medications don't eliminate hunger entirely, is actually well-supported. GLP-1 receptor agonists reduce appetite through several mechanisms, including slowing gastric emptying and acting on hypothalamic satiety centers, but they do not switch hunger off like a light switch for everyone.

Wilding et al. (2021, New England Journal of Medicine), the landmark semaglutide trial, showed significant weight loss in participants, but also documented that a meaningful proportion reported nausea, vomiting, and gastrointestinal distress as the most common side effects, not complete appetite suppression. Hunger can persist, particularly between dose escalations or at lower doses. Jastreboff et al. (2022, New England Journal of Medicine) found similar patterns with tirzepatide. The lived experience of still feeling hungry while on a GLP-1 medication is real and documented, not a sign the medication is failing.

What did they get wrong (or right)?

There isn't enough spoken content here to identify a factual error. The creator didn't make a clinical claim, didn't recommend a dose, and didn't oversell the medication. Saying "I'm hungry and I wish I had a snack" while on a GLP-1 is an honest, accurate reflection of how these medications actually work for many people.

What the creator got right, even implicitly, is pushing back on the popular narrative that GLP-1 drugs are a effortless cure that removes all desire to eat. That myth has real consequences. Patients who expect complete appetite elimination may interpret ongoing hunger as treatment failure and either increase their dose unsafely or abandon treatment. The creator's willingness to show the less glamorous side of the experience is genuinely useful public health communication, even if the transcript itself is fragmentary.

One caveat: the caption mentions side effects are "not fun" without specifying what they are. GLP-1 side effects vary considerably and some, like severe nausea or gastroparesis in rare cases, warrant clinical attention. Personal experience videos are valuable but shouldn't substitute for speaking with a prescriber about specific symptoms.

What should you actually know?

GLP-1 receptor agonists work differently from person to person. Nausea and gastrointestinal symptoms are the most commonly reported side effects, particularly during dose escalation. Hunger reduction is real for most patients, but it is rarely total, and it tends to be more pronounced at higher doses.

If you're on a GLP-1 medication and still feeling hungry, that does not mean the medication isn't working. Weight loss on these drugs typically occurs over months, not weeks, and appetite changes can lag behind dose increases. Davies et al. (2021, Diabetes Care) noted that individual response variability is significant across GLP-1 therapies. Tracking symptoms and reporting them to your prescriber is more useful than adjusting expectations based on social media content, even well-intentioned content like this video. A telehealth provider can help distinguish normal adjustment-phase symptoms from side effects that need managing.